These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2068485)

  • 1. [What is mastopathy at risk? Epidemiologic and clinical basis].
    Gorins A; Kottler ML
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):4-8. PubMed ID: 2068485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [When must a mastopathy at risk be operated on? The viewpoint of the clinician, the radiologist, the surgeon, and the anatomopathologist].
    Gorins A; Dilhuydy MH; Petit JY; Contesso G
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):15-20. PubMed ID: 2068479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mastopathy. Histological forms and long-term observations].
    Prechtel K
    Zentralbl Pathol; 1991; 137(3):210-9. PubMed ID: 1931894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal and environmental factors affecting cell proliferation and neoplasia in the mammary gland.
    Snedeker SM; Diaugustine RP
    Prog Clin Biol Res; 1996; 394():211-53. PubMed ID: 8778798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is "mastopathy at risk" for the anatomopathologist?].
    Contesso G; Bertin F; Terrier P; Petit JY; Le M
    Rev Fr Gynecol Obstet; 1991 Jan; 86(1):9-12. PubMed ID: 2068489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of benign and preinvasive breast diseases.
    Altaf FJ; Abdullah LS; Jamal AA
    Saudi Med J; 2004 Apr; 25(4):493-7. PubMed ID: 15083223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of susceptibility to breast cancer.
    Hulka BS
    Prog Clin Biol Res; 1996; 395():159-74. PubMed ID: 8895988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin and breast cancer risk.
    Ingram DM; Nottage EM; Roberts AN
    Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors for breast cancer. Do epidemiologic findings provide a basis for primary prevention?].
    Kvåle G; Jacobsen BK
    Tidsskr Nor Laegeforen; 1990 Jan; 110(2):232-5. PubMed ID: 2405544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K; Zych F
    Pol Merkur Lekarski; 1997 May; 2(11):303-6. PubMed ID: 9377675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer epidemiology.
    Kelsey JL; Berkowitz GS
    Cancer Res; 1988 Oct; 48(20):5615-23. PubMed ID: 3048646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some insufficiently recognized risk factors for breast cancer].
    Kocić B; Janković S; Petrović B; Tiodorović B
    Srp Arh Celok Lek; 1996; 124(7-8):175-8. PubMed ID: 9102842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epidemiologic and prognostic factors of cancer of the breast].
    Rouëssé J; Berlie J; Hacene K; Brunet M; Spyratos F
    Rev Prat; 1990 Apr; 40(10):885-9. PubMed ID: 2326574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk.
    Zheng W; Xie D; Cerhan JR; Sellers TA; Wen W; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):89-94. PubMed ID: 11219777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.